Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05101317 · ClinicalTrials.gov registry record · Phase 2

A Study to Assess the Efficacy and Safety of HMI-115 in Subjects With Endometriosis-Associated Pain

A Phase 2 study of Endometriosis, sponsored by Hope Medicine (Nanjing) Co..

Completed
Registry status
Phase 2
Development phase
142
Enrollment target
5
Study locations

NCT05101317 is a Phase 2 study of Endometriosis that has completed, run by Hope Medicine (Nanjing) Co.. The registered enrollment target is 142 participants, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05101317, a Phase 2 study of Endometriosis, has completed, sponsored by Hope Medicine (Nanjing) Co..

COMPLETED
Registry status
Phase 2
Development phase
142 participants
Enrollment target
5
Study locations

Study Summary

This study is designed to evaluate the safety and efficacy of HMI-115 compared to placebo over a 12 weeks period on subjects with moderate to severe endometriosis-associated pain.

Conditions Studied

Endometriosis

Interventions

  • DRUG Placebo
  • DRUG HMI-115

Study Locations (5)

Utah

  • Physicians' Research Options, LLC- Corner Canyon Clinic - Draper

Virginia

  • Tidewater Clinical Research/TPW - Norfolk

Beijing Municipality

  • Peking Union Medical College Hospital - Beijing

Masovian Voivodeship

  • Instytut Matki i Dziecka - Warsaw

Podlaskie Voivodeship

  • Specjalistyczna Poradnia Ginekologiczna Gabinet Ginekologiczny Dr med. Janusza Tomaszewskiego - Bialystok

Trial Details

FieldValue
Enrollment Target 142 participants
Start Date 2021-10-11
Est. Completion 2025-03-19
Phase Phase 2

Sponsor

Hope Medicine (Nanjing) Co.

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05101317

The ClinicalTrials.gov registry entry for NCT05101317 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower). The listed sponsor is Hope Medicine (Nanjing) Co., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05101317 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Utah, Virginia, Beijing Municipality.

Frequently Asked Questions

What is clinical trial NCT05101317 about?

NCT05101317 is a clinical study titled "A Study to Assess the Efficacy and Safety of HMI-115 in Subjects With Endometriosis-Associated Pain". This study is designed to evaluate the safety and efficacy of HMI-115 compared to placebo over a 12 weeks period on subjects with moderate to severe endometriosis-associated pain.

What is the current status of trial NCT05101317?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 142 participants. The study started on 2021-10-11. Estimated completion is 2025-03-19.

What conditions does trial NCT05101317 study?

This clinical trial studies the following conditions: Endometriosis.

What interventions are being tested in trial NCT05101317?

The interventions under investigation include: Placebo (DRUG), HMI-115 (DRUG).

Who is sponsoring clinical trial NCT05101317?

This trial is sponsored by Hope Medicine (Nanjing) Co., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05101317 being conducted?

This trial has 5 study locations across Utah, Virginia, Beijing Municipality, Masovian Voivodeship, Podlaskie Voivodeship. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Endometriosis

All registered trials for this condition

Utah

All trials with a study site in Utah

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.